Vicky Shih has nearly 10 years of extensive healthcare investment experience across the APAC region, leading several investments from Seed through Series B. She has led numerous transactions within investment management, financing and licensing which IPO’d, such as Bora, Foresee, Frequency Therapeutics and C4 Therapeutics. Her previous professional experiences include VP at CTBC Capital; Head of Business Development – APAC at SmartLabs; Principal at Axil Capital; and Investment Manager at Taian Venture Capital.

Vicky holds a PhD in Neuroscience & BS in Life Science from National Tsinghua University.